KL and type 2 diabetes mellitus: The study confirmed significant associations between α-Klotho and a reduced risk of cardiometabolic diseases in middle-aged and elderly populations and unveiled non-linear dose-response relationships with T2DM and CKD risks, characterized by U-shaped and L-shaped patterns, respectively.